Diego Alberti

Turin, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications

Nose-to-brain delivery of a novel boronated curcuminoid via cyclodextrins: Biodistribution toward potential BNCT applications in Alzheimer's disease.

Nose-to-brain delivery of a novel boronated curcuminoid via cyclodextrins: Biodistribution toward potential BNCT applications in Alzheimer's disease.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: May 11, 2026

Carboranyl-Curcuminoids for the Neutron Capture-Based Treatment of Amyloid Aggregates in Alzheimer's Disease.

Carboranyl-Curcuminoids for the Neutron Capture-Based Treatment of Amyloid Aggregates in Alzheimer's Disease.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 30, 2025

A Comparative Study of 157Gd and 10B Effect in a Carborane-Based Theranostic Agent for Membrane-Targeted Carbonic Anhydrase IX Inhibition and MRI-Guided Neutron Capture Therapy in Mesothelioma Treatment.

A Comparative Study of 157Gd and 10B Effect in a Carborane-Based Theranostic Agent for Membrane-Targeted Carbonic Anhydrase IX Inhibition and MRI-Guided Neutron Capture Therapy in Mesothelioma Treatment.

Journal: ACS central science
Published: August 28, 2025

Cobaltabis(dicarbollide) [o-COSAN]- loaded apoferritin: an innovative high-capacity boron delivery system to target tumour cells for BNCT applications.

Cobaltabis(dicarbollide) [o-COSAN]- loaded apoferritin: an innovative high-capacity boron delivery system to target tumour cells for BNCT applications.

Journal: Nanoscale
Published: April 22, 2025

A radical containing micellar probe for assessing esterase enzymatic activity with ultra-low field Overhauser-enhanced magnetic resonance imaging.

A radical containing micellar probe for assessing esterase enzymatic activity with ultra-low field Overhauser-enhanced magnetic resonance imaging.

Journal: Journal of materials chemistry. B
Published: September 27, 2024

Combining BNCT with carbonic anhydrase inhibition for mesothelioma treatment: Synthesis, in vitro, in vivo studies of ureidosulfamido carboranes.

Combining BNCT with carbonic anhydrase inhibition for mesothelioma treatment: Synthesis, in vitro, in vivo studies of ureidosulfamido carboranes.

Journal: European journal of medicinal chemistry
Published: January 22, 2024

4-Amino-TEMPO loaded liposomes as sensitive EPR and OMRI probes for the detection of phospholipase A2 activity.

4-Amino-TEMPO loaded liposomes as sensitive EPR and OMRI probes for the detection of phospholipase A2 activity.

Journal: Scientific reports
Published: June 29, 2023

A novel pH sensitive theranostic PLGA nanoparticle for boron neutron capture therapy in mesothelioma treatment.

A novel pH sensitive theranostic PLGA nanoparticle for boron neutron capture therapy in mesothelioma treatment.

Journal: Scientific reports
Published: November 13, 2022

Biotinylation of a MRI/Gd BNCT theranostic agent to access a novel tumour-targeted delivery system.

Biotinylation of a MRI/Gd BNCT theranostic agent to access a novel tumour-targeted delivery system.

Journal: Organic & biomolecular chemistry
Published: June 24, 2022

Highly Sensitive "Off/On" EPR Probes to Monitor Enzymatic Activity.

Highly Sensitive "Off/On" EPR Probes to Monitor Enzymatic Activity.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: December 23, 2021

LDL mediated delivery of Paclitaxel and MRI imaging probes for personalized medicine applications.

LDL mediated delivery of Paclitaxel and MRI imaging probes for personalized medicine applications.

Journal: Journal of nanobiotechnology
Published: April 30, 2021

Towards Enhanced MRI Performance of Tumor-Specific Dimeric Phenylboronic Contrast Agents.

Towards Enhanced MRI Performance of Tumor-Specific Dimeric Phenylboronic Contrast Agents.

Journal: Molecules (Basel, Switzerland)
Published: February 21, 2021
Showing 1-12 of 35

Last Updated: 09/26/2026